Healthcare Services

Solid Tumor Cancer Treatment Market Revenue Anticipated To Reach $501.27 Billion By 2030 With 13.6% CAGR

June 3, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Solid Tumor Cancer Treatment Market By 2030 Based On Its 2026 Value?

The solid tumor cancer treatment market has shown significant growth in recent years. Its value is expected to rise from $265.41 billion in 2025 to $301.06 billion in 2026, at a compound annual growth rate (CAGR) of 13.4%. Historically, this expansion has been driven by increasing cancer incidence, broader adoption of chemotherapy, advancements in radiation therapy, increased oncology funding, and improved early diagnosis techniques.

The solid tumor cancer treatment market is projected for significant expansion in the coming years, with its valuation anticipated to reach $501.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.6%. This projected growth is driven by factors such as the approval of immunotherapies, a robust pipeline of targeted drugs, the increasing adoption of personalized medicine, the expansion of oncology infrastructure, and advancements in survival rates. Key trends expected during this period involve the proliferation of checkpoint inhibitors, the development of tumor-agnostic therapies, an uptick in combination treatment regimens, the emergence of biomarker-driven treatments, and an expansion in outpatient oncology services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9909&type=smp

What Market Drivers Are Helping Shape The Solid Tumor Cancer Treatment Market Expansion?

The rising occurrence of cancer significantly contributes to the expansion of the solid tumor cancer treatment market moving forward. Cancer is a severe illness marked by the rapid and uncontrolled multiplication of the body’s cells, leading to abnormal tissue growth. Solid tumor cancer treatment refers to therapeutic approaches utilized for the removal of solid tumors from the bodies of cancer patients. For instance, in April 2024, the World Health Organization, a Switzerland-based international public health organization, reported that in 2022, nearly 20 million new cancer cases were identified, resulting in approximately 10 million deaths from the disease. Demographic forecasts suggest that the annual incidence of cancer could reach 35 million by 2050, which is a 77% increase from 2022 figures. Lung cancer was the most commonly diagnosed type, accounting for about 2.5 million new cases, or one in every eight cancers globally, representing 12.4% of all cancers worldwide. Therefore, an increasing incidence of cancer is a key driver for the growth of the solid tumor cancer treatment market.

Which Segment Divisions Form The Structure Of The Solid Tumor Cancer Treatment Market?

The solid tumor cancer treatment market covered in this report is segmented –

1) By Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures

2) By Application: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications

3) By End-Users: Hospitals, Research Institutes, Homecare

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Mitotic Inhibitors

2) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Signal Transduction Inhibitors

3) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines

4) By Hormone Therapy: Aromatase Inhibitors, Anti-Androgens, Selective Estrogen Receptor Modulators (SERMs)

5) By Surgical Procedures: Tumor Resection, Laparoscopic Surgery, Robotic-Assisted Surgery

Which Trends Are Influencing The Direction Of The Solid Tumor Cancer Treatment Market?

Key players in the soft tissue sarcoma market are focusing on developing novel products to enhance their market standing. An example of this is Mercy, a US-based not-for-profit Catholic healthcare organization, which launched an innovative AI-driven texting program named The Chen Chemotherapy Model in November 2023. This initiative aims to preemptively avoid chemotherapy-related hospitalizations. The program employs a smart texting platform that delivers daily messages to chemotherapy patients seven days a week, with the exception of weekends and holidays. These texts present a selection of symptoms, such as diarrhea, pain, fever, fatigue, nausea or vomiting, or the option to report no symptoms. Patients are able to choose and rate their symptoms, and depending on their input, this data can be escalated to their healthcare provider. The objective is to identify potential issues at an early stage and intervene prior to symptom deterioration, illustrating Mercy’s dedication to utilizing technology for better patient care in chemotherapy.

Which Companies Form The Competitive Landscape Of The Solid Tumor Cancer Treatment Market?

Major companies operating in the solid tumor cancer treatment market are AstraZeneca plc, Amgen Inc., Bristol Myers Squibb & Company, Eli Lilly & Company, F Hoffmann La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, Olympus Medical Systems, Astellas Pharma Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd, Celldex Therapeutics Inc, AbbVie Inc, Bayer AG, Eisai Co Ltd, Exelixis Inc, Genentech Inc, Gilead Sciences Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Karyopharm Therapeutics Inc, Kyowa Kirin Co Ltd, MorphoSys AG, Regeneron Pharmaceuticals Inc, Sanofi SA, Seattle Genetics Inc, Spectrum Pharmaceuticals Inc, Taiho Pharmaceutical Co Ltd, Verastem Inc, Zymeworks Inc

Access The Complete Solid Tumor Cancer Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Which Geographic Region Represents The Largest Solid Tumor Cancer Treatment Market Share?

North America was the largest region in the solid tumor cancer treatment market in 2025. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Solid Tumor Cancer Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9909&type=smp

Browse Through More Reports Similar to the Global Solid Tumor Cancer Treatment Market 2026, By The Business Research Company

Solid Tumor Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Bone Cancer Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

Intratumoral Cancer Therapies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795